Intelligence · Clinical pipeline
Autoimmune & immunology R&D Pipeline
Autoimmune, rheumatology, and immunology biologics in clinical development.
Quick answer
Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.
Top sponsors
- Takeda 87 programs
- Chinese Academy of 58 programs
- Anaxis Pharma 52 programs
- Janssen-Cilag International N.V 34 programs
- Novartis India 32 programs
- First People's Hospital 23 programs
- Lakefront Biotherapeutics NV 22 programs
- AbbVie 21 programs
- AbbVie Deutschland GmbH 20 programs
- Regeneron UK 20 programs
- HOFFMANN-LA ROCHE 19 programs
- Pacira Ireland 18 programs
Pipeline programs
-
An open-label for inteneded for treatment of - ac…
Lacuna Pharma Pty Ltd
inteneded for treatment of - active rheumatoid arthritis in adult patients, - polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs has been inadequate, - severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy and severe psoriatic arthritis in adult patients, - mild-to-moderate Crohn’s disease, either alone or in combination with corticosteroids, in adult patients refractory or intolerant to thiopurines.
1 trial -
Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
Takeda
Systemic Lupus Erythematosus
1 trial -
Atorvastatin
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
Azercabtagene zapreleucel (azer-cel)
TG THERAPEUTICS, INC.
B-cell Mediated Autoimmune Disorders
1 trial -
BCMA/CD70 CAR-T cells
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
BMS-986202
Bristol-Myers Squibb
Psoriasis
1 trial -
C6341001
Pfizer Australia Pty Ltd
Rheumatoid arthritis and Systemic Lupus Erythematosus
1 trial -
CA061-1001
Celgene Europe Limited
Systemic Sclerosis, Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathy, Systemic Lupus Erythematosus (SLE)
1 trial -
CA061-1006
Celgene Europe Limited
Myasthenia gravis (MG), Progressive Multiple Sclerosis (PMS), Relapsing Multiple Sclerosis (RMS)
1 trial -
CAIN457E22101
Novartis Pharmaceuticals
Polymyalgia rheumatica (PMR), Giant cell arteritis (GCA)
1 trial -
CB-010
Caribou Biosciences
Systemic Lupus Erythematosus
1 trial -
CBP-307
S.L
Autoimmune Diseases
2 trials -
CBP-307
Connect Biopharm
Autoimmune Diseases
1 trial -
CD19 CAR-T cells
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
CD19 targeted CAR-T cells
Chongqing Precision Biotech Co., Ltd
SLE (Systemic Lupus)
1 trial -
CD19/BCMA in vivo CAR-T
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Diseases
1 trial -
CLN-978
Cullinan Therapeutics
Rheumatoid Arthritis (RA
1 trial -
CLN-978-RA-101
Cullinan Therapeutics
Treatment-Refractory Rheumatoid Arthritis
1 trial -
CLN-978-SL-101
Cullinan Therapeutics
Systemic Lupus Erythematosus
1 trial -
CNCT19 CAR-T cell therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hemolytic Anemia
1 trial -
CNCT19 cell injection
Juventas Cell Therapy
Neurological Autoimmune Diseases
1 trial -
CNTY-101
Century Therapeutics
Systemic Lupus Erythematosus
1 trial -
CNTY-101-151-01
Century Therapeutics
systemic lupus erythematosus [SLE]/lupus nephritis [LN], idiopathic inflammatory myopathy [IIM], and diffuse cutaneous systemic sclerosis [DcSSc]
1 trial -
CNTY-LTFU-01
Century Therapeutics
Hematological or solid tumor malignancies or autoimmune diseases
1 trial -
CPIT565B12101
Novartis Pharmaceuticals
Systemic Lupus Erythematosus
1 trial -
CPIT565C12101
Novartis Pharmaceuticals
Rheumatoid Arthritis
1 trial -
CTX112
S.A.
SLE (Systemic Lupus)
1 trial -
D740AC00001
AstraZeneca AB
Systemic Lupus Erythematosus, Rheumatoid Arthritis
1 trial -
D9640C00001
AstraZeneca AB
Rheumatoid Arthritis
1 trial -
D9690C00007
AstraZeneca AB
Crohn's disease
1 trial -
D9961C00001
AstraZeneca AB
Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
1 trial -
DEUCR-07-25
Lacuna Pharma Pty Ltd
plaque psoriasis
1 trial -
DEUCR-08-25
Lacuna Pharma Pty Ltd
plaque psoriasis
1 trial -
Delayed Release 6 mercaptopurine
Teva Pharma GmbH
Crohns Disease
1 trial -
EP-104IAR
EUPRAXIA PHARMACEUTICALS INC.
Osteoarthritis, Knee
1 trial -
Effect of Renal Impairment on Enpatoran Pharmacokinetics
Merck Sharp and Dohme
Healthy volunteers and patients with renal impairment; Intended indication: autoimmune diseases; systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE), as well as dermatomyositis (DM) and polymyositis (PM).
1 trial -
Etrasimod Arginine Blue
Pfizer Australia Pty Ltd
Ulcerative Colitis and immune-mediated inflammatory disorders
1 trial -
FT819 in B-cell Mediated Autoimmune Diseases
Zafatek
B-cell Mediated Autoimmune Diseases
1 trial -
FX201
Pacira Ireland Limited
Osteoarthritis, Knee
1 trial -
Fasinumab AI
Regeneron UK Limited
Osteoarthritis, Knee
1 trial -
GA43191
Hoffmann-La Roche
Systemic Lupus Erythematosus (SLE)
1 trial -
GA46438
Hoffmann-La Roche
Active Ulcerative Colitis (UC)
1 trial -
GBP-NIB1-101
Lacuna Pharma Pty Ltd
rheumatoid arthritis
1 trial -
GLPG-0634-CL-131
Alfasigma S.p.A.
juvenile idiopathic arthritis
1 trial -
GLPG1972 600 mg oral solution fasted
Lakefront Biotherapeutics NV
Osteoarthritis
1 trial -
GLPG1972 cohort 1
Lakefront Biotherapeutics NV
Osteoarthritis
1 trial -
GLPG3667
Lakefront Biotherapeutics NV
Plaque Psoriasis
1 trial -
GLPG3970 film-coated tablet
Lakefront Biotherapeutics NV
Systemic Lupus Erythematosus
1 trial
Frequently asked questions
How many autoimmune & immunology pipeline programs are tracked?
985 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.